Position in GH
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$312,512
+$59,818 QoQ
Shares Held
2,083
-15.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#411
of 593 holders
Holding Since
Mar 2024
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GH Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026EntryPoint Capital, LLC holds $4,328,155 across 10 Diagnostics & Research names. GH ranks #8 (7.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NTRA |
Natera, Inc.
|
2,582 | $700,883 | |
| 2 | LH |
Labcorp Holdings Inc.
|
2,321 | $649,880 | |
| 3 | FLGT |
Fulgent Genetics, Inc.
|
27,999 | $574,539 | |
| 4 | MEDP |
Medpace Holdings, Inc.
|
1,036 | $548,655 | |
| 5 | A |
Agilent Technologies, Inc.
|
3,150 | $418,414 | |
| 6 | NEO |
Neogenomics Inc
|
23,869 | $348,248 | |
| 7 | IDXX |
Idexx Laboratories Inc /De
|
635 | $334,289 | |
| 8 | GH |
Guardant Health, Inc.
This page
|
2,083 | $312,512 |
All Filings in GH
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $312,512 | 2,083 | Shares | Sole | 2026-08-13 | |
| 2025-12-31 | $252,694 | 2,474 | Shares | Sole | 2026-02-12 | |
| 2024-12-31 | $499,095 | 16,337 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $725,661 | 31,633 | Shares | Sole | 2024-11-13 | |
| 2024-03-31 | $74,928 | 3,632 | Shares | Sole | 2024-05-14 | |
| No filing history on record for this holder in this stock. | ||||||